SIMILAR PATTERNS OF AMINO ACIDS FOR 2C6N_A_LPRA705_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bqb | PROTEIN (AUREOLYSIN) (Staphylococcusaureus) |
PF01447(Peptidase_M4)PF02868(Peptidase_M4_C) | 5 | ALA A 115HIS A 144GLU A 145HIS A 148GLU A 168 | None ZN A 350 (-3.3A) ZN A 350 ( 4.6A) ZN A 350 (-3.3A) ZN A 350 (-2.2A) | 0.49A | 2c6nA-1bqbA:6.6 | 2c6nA-1bqbA:18.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eb6 | NEUTRAL PROTEASE II (Aspergillusoryzae) |
PF02102(Peptidase_M35) | 5 | ALA A 91HIS A 128GLU A 129HIS A 132TYR A 146 | None ZN A 178 (-3.3A) ZN A 178 ( 4.0A) ZN A 178 (-3.3A)None | 0.40A | 2c6nA-1eb6A:3.5 | 2c6nA-1eb6A:14.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1f82 | BOTULINUM NEUROTOXINTYPE B (Clostridiumbotulinum) |
PF01742(Peptidase_M27) | 5 | HIS A 229GLU A 230HIS A 233GLU A 267TYR A 372 | ZN A 500 (-3.2A) ZN A 500 ( 4.2A) ZN A 500 (-3.3A) ZN A 500 (-2.1A)None | 0.87A | 2c6nA-1f82A:2.6 | 2c6nA-1f82A:20.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y79 | PEPTIDYL-DIPEPTIDASEDCP (Escherichiacoli) |
PF01432(Peptidase_M3) | 8 | ALA 1 424HIS 1 469GLU 1 470HIS 1 473GLU 1 498HIS 1 601TYR 1 611TYR 1 614 | GLY 1 703 (-4.8A) ZN 1 700 (-3.2A)TRP 1 702 ( 2.6A) ZN 1 700 ( 3.3A) ZN 1 700 ( 2.2A)TRP 1 702 ( 3.8A)ASP 1 704 (-4.7A)ASP 1 704 (-3.5A) | 0.38A | 2c6nA-1y791:19.8 | 2c6nA-1y791:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fge | ZINC METALLOPROTEASE(INSULINASE FAMILY) (Arabidopsisthaliana) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C)PF08367(M16C_assoc) | 5 | ALA A 110HIS A 81HIS A 77GLU A 177TYR A 854 | None ZN A 996 (-3.2A) ZN A 996 (-3.4A) ZN A 996 (-2.2A)None | 0.49A | 2c6nA-2fgeA:undetectable | 2c6nA-2fgeA:21.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h1n | OLIGOENDOPEPTIDASE F (Geobacillusstearothermophilus) |
PF01432(Peptidase_M3) | 6 | GLN A 477HIS A 356GLU A 357HIS A 360GLU A 384TYR A 490 | None ZN A 601 (-3.3A) ZN A 601 ( 4.9A) ZN A 601 (-3.3A) ZN A 601 (-2.2A)UNL A 605 ( 4.5A) | 1.27A | 2c6nA-2h1nA:24.8 | 2c6nA-2h1nA:23.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h1n | OLIGOENDOPEPTIDASE F (Geobacillusstearothermophilus) |
PF01432(Peptidase_M3) | 7 | HIS A 356GLU A 357HIS A 360GLU A 384HIS A 479TYR A 487TYR A 490 | ZN A 601 (-3.3A) ZN A 601 ( 4.9A) ZN A 601 (-3.3A) ZN A 601 (-2.2A)NoneNoneUNL A 605 ( 4.5A) | 0.41A | 2c6nA-2h1nA:24.8 | 2c6nA-2h1nA:23.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2o36 | THIMETOLIGOPEPTIDASE (Homo sapiens) |
PF01432(Peptidase_M3) | 5 | ALA A 425HIS A 473GLU A 474HIS A 477GLU A 502 | None ZN A 690 (-3.4A) ZN A 690 ( 4.1A) ZN A 690 (-3.3A) ZN A 690 (-2.3A) | 0.55A | 2c6nA-2o36A:16.3 | 2c6nA-2o36A:23.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2o36 | THIMETOLIGOPEPTIDASE (Homo sapiens) |
PF01432(Peptidase_M3) | 5 | ALA A 425HIS A 473GLU A 474HIS A 477TYR A 612 | None ZN A 690 (-3.4A) ZN A 690 ( 4.1A) ZN A 690 (-3.3A)None | 1.24A | 2c6nA-2o36A:16.3 | 2c6nA-2o36A:23.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2o3e | NEUROLYSIN (Rattusnorvegicus) |
PF01432(Peptidase_M3) | 6 | ALA A 426HIS A 474GLU A 475HIS A 478GLU A 503TYR A 613 | None ZN A 679 (-3.4A) ZN A 679 ( 4.5A) ZN A 679 (-3.3A) ZN A 679 (-2.1A)None | 1.02A | 2c6nA-2o3eA:18.4 | 2c6nA-2o3eA:22.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qn0 | NEUROTOXIN (Clostridiumbotulinum) |
PF01742(Peptidase_M27) | 5 | HIS A 229GLU A 230HIS A 233GLU A 269TYR A 375 | ZN A 431 (-3.3A) ZN A 431 ( 4.0A) ZN A 431 (-3.3A) ZN A 431 (-2.1A)None | 0.96A | 2c6nA-2qn0A:2.8 | 2c6nA-2qn0A:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xpz | LEUKOTRIENE A-4HYDROLASE (Saccharomycescerevisiae) |
PF01433(Peptidase_M1)PF09127(Leuk-A4-hydro_C) | 5 | HIS A 340GLU A 341HIS A 344GLU A 363TYR A 429 | ZN A1673 (-3.3A)None ZN A1673 (-3.5A) ZN A1673 (-2.2A)None | 0.88A | 2c6nA-2xpzA:5.8 | 2c6nA-2xpzA:21.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2xy9 | ANGIOTENSIN-CONVERTING ENZYME (Homo sapiens) |
PF01401(Peptidase_M2) | 11 | GLN A 281HIS A 353ALA A 354HIS A 383GLU A 384HIS A 387GLU A 411LYS A 511HIS A 513TYR A 520TYR A 523 | 3ES A1635 (-3.3A)3ES A1635 (-3.8A)3ES A1635 (-4.2A) ZN A1628 ( 3.2A)3ES A1635 (-2.8A) ZN A1628 ( 3.2A) ZN A1628 ( 2.4A)3ES A1635 (-2.6A)3ES A1635 (-3.9A)3ES A1635 (-4.7A)3ES A1635 (-3.4A) | 0.33A | 2c6nA-2xy9A:53.0 | 2c6nA-2xy9A:55.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2xy9 | ANGIOTENSIN-CONVERTING ENZYME (Homo sapiens) |
PF01401(Peptidase_M2) | 6 | HIS A 353GLN A 369LYS A 511HIS A 513TYR A 520TYR A 523 | 3ES A1635 (-3.8A)None3ES A1635 (-2.6A)3ES A1635 (-3.9A)3ES A1635 (-4.7A)3ES A1635 (-3.4A) | 1.25A | 2c6nA-2xy9A:53.0 | 2c6nA-2xy9A:55.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2xyd | ANGIOTENSIN-CONVERTING ENZYME (Homo sapiens) |
PF01401(Peptidase_M2) | 11 | GLN A 259HIS A 331ALA A 332HIS A 361GLU A 362HIS A 365GLU A 389LYS A 489HIS A 491TYR A 498TYR A 501 | 3ES A1611 (-3.1A)3ES A1611 (-3.8A)3ES A1611 (-4.3A)3ES A1611 ( 3.2A)3ES A1611 (-2.5A) ZN A1620 ( 3.2A) ZN A1620 ( 2.4A)3ES A1611 (-2.6A)3ES A1611 (-3.9A)3ES A1611 (-4.7A)3ES A1611 (-3.5A) | 0.34A | 2c6nA-2xydA:56.9 | 2c6nA-2xydA:98.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2xyd | ANGIOTENSIN-CONVERTING ENZYME (Homo sapiens) |
PF01401(Peptidase_M2) | 11 | GLN A 259HIS A 331GLN A 355HIS A 361GLU A 362HIS A 365GLU A 389LYS A 489HIS A 491TYR A 498TYR A 501 | 3ES A1611 (-3.1A)3ES A1611 (-3.8A)None3ES A1611 ( 3.2A)3ES A1611 (-2.5A) ZN A1620 ( 3.2A) ZN A1620 ( 2.4A)3ES A1611 (-2.6A)3ES A1611 (-3.9A)3ES A1611 (-4.7A)3ES A1611 (-3.5A) | 0.49A | 2c6nA-2xydA:56.9 | 2c6nA-2xydA:98.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2xyd | ANGIOTENSIN-CONVERTING ENZYME (Homo sapiens) |
PF01401(Peptidase_M2) | 8 | HIS A 331ALA A 332HIS A 365GLU A 362GLU A 389HIS A 491TYR A 498TYR A 501 | 3ES A1611 (-3.8A)3ES A1611 (-4.3A) ZN A1620 ( 3.2A)3ES A1611 (-2.5A) ZN A1620 ( 2.4A)3ES A1611 (-3.9A)3ES A1611 (-4.7A)3ES A1611 (-3.5A) | 1.46A | 2c6nA-2xydA:56.9 | 2c6nA-2xydA:98.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2xyd | ANGIOTENSIN-CONVERTING ENZYME (Homo sapiens) |
PF01401(Peptidase_M2) | 6 | HIS A 331GLN A 347HIS A 365HIS A 491TYR A 498TYR A 501 | 3ES A1611 (-3.8A)None ZN A1620 ( 3.2A)3ES A1611 (-3.9A)3ES A1611 (-4.7A)3ES A1611 (-3.5A) | 1.37A | 2c6nA-2xydA:56.9 | 2c6nA-2xydA:98.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2xyd | ANGIOTENSIN-CONVERTING ENZYME (Homo sapiens) |
PF01401(Peptidase_M2) | 6 | HIS A 331GLN A 347LYS A 489HIS A 491TYR A 498TYR A 501 | 3ES A1611 (-3.8A)None3ES A1611 (-2.6A)3ES A1611 (-3.9A)3ES A1611 (-4.7A)3ES A1611 (-3.5A) | 1.26A | 2c6nA-2xydA:56.9 | 2c6nA-2xydA:98.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yd0 | ENDOPLASMICRETICULUMAMINOPEPTIDASE 1 (Homo sapiens) |
PF01433(Peptidase_M1)PF11838(ERAP1_C) | 6 | ALA A 318HIS A 353GLU A 354HIS A 357GLU A 376TYR A 438 | BES A1950 (-4.9A) ZN A1946 ( 3.3A)BES A1950 (-3.3A)BES A1950 ( 3.3A) ZN A1946 ( 2.1A)BES A1950 (-4.3A) | 0.72A | 2c6nA-2yd0A:6.6 | 2c6nA-2yd0A:21.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ahm | OLIGOPEPTIDASE (Geobacillus sp.MO-1) |
no annotation | 6 | GLN A 477HIS A 356GLU A 357HIS A 360GLU A 384TYR A 490 | ACT A 567 (-3.5A) ZN A 565 (-3.4A) ZN A 565 ( 4.6A) ZN A 565 (-3.3A) ZN A 565 (-2.1A)ACT A 567 (-3.6A) | 1.24A | 2c6nA-3ahmA:25.1 | 2c6nA-3ahmA:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ahm | OLIGOPEPTIDASE (Geobacillus sp.MO-1) |
no annotation | 7 | HIS A 356GLU A 357HIS A 360GLU A 384HIS A 479TYR A 487TYR A 490 | ZN A 565 (-3.4A) ZN A 565 ( 4.6A) ZN A 565 (-3.3A) ZN A 565 (-2.1A)ACT A 567 (-4.6A)ACT A 567 (-4.5A)ACT A 567 (-3.6A) | 0.36A | 2c6nA-3ahmA:25.1 | 2c6nA-3ahmA:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3amj | ZINC PEPTIDASEACTIVE SUBUNIT (Sphingomonassp. A1) |
no annotation | 5 | ALA C 108HIS C 81GLU C 80HIS C 77GLU C 157 | None ZN C 1 (-3.4A) ZN C 1 ( 4.4A) ZN C 1 (-3.2A) ZN C 1 (-1.9A) | 0.68A | 2c6nA-3amjC:undetectable | 2c6nA-3amjC:20.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3c37 | PEPTIDASE, M48FAMILY (Geobactersulfurreducens) |
PF01435(Peptidase_M48) | 5 | ALA A 78HIS A 208GLU A 107HIS A 106GLU A 162 | None ZN A 301 (-3.1A)None ZN A 301 (-3.2A) ZN A 301 (-2.2A) | 1.20A | 2c6nA-3c37A:undetectable | 2c6nA-3c37A:17.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ce2 | PUTATIVE PEPTIDASE (Chlamydiaabortus) |
PF01432(Peptidase_M3)PF08439(Peptidase_M3_N) | 5 | ALA A 372HIS A 400GLU A 401HIS A 404GLU A 428 | None ZN A 703 (-3.3A) ZN A 703 ( 4.7A) ZN A 703 (-3.4A) ZN A 703 (-2.9A) | 0.65A | 2c6nA-3ce2A:16.8 | 2c6nA-3ce2A:22.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cia | COLD-ACTIVEAMINOPEPTIDASE (Colwelliapsychrerythraea) |
PF01433(Peptidase_M1)PF09127(Leuk-A4-hydro_C) | 5 | HIS A 324GLU A 325HIS A 328GLU A 347TYR A 410 | ZN A 701 (-4.1A) ZN A 701 ( 4.6A) ZN A 701 (-3.8A) ZN A 701 (-3.4A)None | 0.83A | 2c6nA-3ciaA:4.1 | 2c6nA-3ciaA:22.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dbk | ELASTASE (Pseudomonasaeruginosa) |
PF01447(Peptidase_M4)PF02868(Peptidase_M4_C) | 5 | ALA A 113HIS A 140GLU A 141HIS A 144GLU A 164 | RDF A2001 (-4.3A) ZN A 302 ( 3.2A)RDF A2001 (-2.7A) ZN A 302 ( 3.2A) ZN A 302 ( 2.2A) | 0.30A | 2c6nA-3dbkA:6.8 | 2c6nA-3dbkA:17.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dc8 | DIHYDROPYRIMIDINASE (Sinorhizobiummeliloti) |
PF01979(Amidohydro_1) | 5 | HIS A 236GLN A 263HIS A 205HIS A 180TYR A 152 | ZN A 501 (-3.4A)NoneNone ZN A 501 (-3.1A)None | 1.33A | 2c6nA-3dc8A:undetectable | 2c6nA-3dc8A:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dwb | ENDOTHELIN-CONVERTING ENZYME 1 (Homo sapiens) |
PF01431(Peptidase_M13)PF05649(Peptidase_M13_N) | 5 | ALA A 567HIS A 607GLU A 608HIS A 611GLU A 667 | RDF A 817 (-4.4A) ZN A 771 ( 3.4A)RDF A 817 (-2.4A) ZN A 771 ( 3.3A) ZN A 771 ( 2.1A) | 0.38A | 2c6nA-3dwbA:4.3 | 2c6nA-3dwbA:22.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3eoq | PUTATIVE ZINCPROTEASE (Thermusthermophilus) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C) | 5 | ALA A 77HIS A 50GLU A 49HIS A 46GLU A 125 | None | 0.68A | 2c6nA-3eoqA:2.5 | 2c6nA-3eoqA:23.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fii | BOTULINUM NEUROTOXINTYPE F (Clostridiumbotulinum) |
PF01742(Peptidase_M27) | 5 | HIS A 227GLU A 228HIS A 231GLU A 266TYR A 368 | ZN A 822 ( 3.5A)00C B 58 (-3.0A) ZN A 822 (-3.4A) ZN A 822 ( 2.0A)00C B 58 (-4.8A) | 0.87A | 2c6nA-3fiiA:3.1 | 2c6nA-3fiiA:20.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hdi | PROCESSING PROTEASE (Bacillushalodurans) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C) | 5 | ALA A 77HIS A 50GLU A 49HIS A 46GLU A 126 | None CO A 500 (-3.4A) CO A 500 ( 4.3A) CO A 500 (-3.4A) CO A 500 (-2.1A) | 0.59A | 2c6nA-3hdiA:undetectable | 2c6nA-3hdiA:20.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hoa | THERMOSTABLECARBOXYPEPTIDASE 1 (Thermusthermophilus) |
PF02074(Peptidase_M32) | 5 | HIS A 276GLU A 277HIS A 280GLU A 306TYR A 430 | None | 0.93A | 2c6nA-3hoaA:21.0 | 2c6nA-3hoaA:23.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hq2 | BACILLUS SUBTILISM32 CARBOXYPEPTIDASE (Bacillussubtilis) |
PF02074(Peptidase_M32) | 7 | HIS A 234HIS A 265GLU A 266HIS A 269GLU A 295HIS A 408TYR A 420 | None ZN A 502 ( 3.4A)PO4 A 503 (-3.0A) ZN A 502 ( 3.3A) ZN A 502 ( 2.2A)NonePO4 A 503 (-4.2A) | 0.60A | 2c6nA-3hq2A:22.6 | 2c6nA-3hq2A:23.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hwp | PHLG (Pseudomonasprotegens) |
no annotation | 5 | ALA A 158HIS A 129GLU A 160HIS A 270GLU A 274 | None ZN A 295 (-3.3A) ZN A 295 (-2.9A) ZN A 295 (-3.3A) ZN A 295 (-2.5A) | 1.15A | 2c6nA-3hwpA:undetectable | 2c6nA-3hwpA:18.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3iuk | UNCHARACTERIZEDPROTEIN (Paenarthrobacteraurescens) |
PF05960(DUF885) | 5 | HIS A 385GLU A 386HIS A 391GLU A 420TYR A 514 | MG A 560 ( 4.9A) MG A 560 (-2.6A) MG A 560 (-3.5A) MG A 560 ( 3.9A)None | 0.89A | 2c6nA-3iukA:3.7 | 2c6nA-3iukA:22.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nqx | SECRETEDMETALLOPROTEASEMCP02 (Pseudoalteromonassp. SM9913) |
PF01447(Peptidase_M4)PF02868(Peptidase_M4_C) | 5 | ALA A 318HIS A 345GLU A 346HIS A 349GLU A 369 | None ZN A 1 (-3.2A) ZN A 1 ( 4.5A) ZN A 1 (-3.2A) ZN A 1 (-2.3A) | 0.42A | 2c6nA-3nqxA:6.9 | 2c6nA-3nqxA:18.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o0y | LIPOPROTEIN (Colwelliapsychrerythraea) |
PF05960(DUF885) | 5 | HIS A 438GLU A 439HIS A 444GLU A 471TYR A 556 | NoneSO4 A 610 ( 4.7A)NoneSO4 A 610 ( 4.2A)SO4 A 610 (-4.2A) | 0.69A | 2c6nA-3o0yA:5.8 | 2c6nA-3o0yA:20.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oaj | PUTATIVERING-CLEAVINGDIOXYGENASE MHQO (Bacillussubtilis) |
PF00903(Glyoxalase) | 5 | ALA A 254HIS A 11GLU A 266HIS A 218TYR A 50 | SO4 A 501 ( 4.6A) ZN A 500 ( 3.3A) ZN A 500 ( 2.1A) ZN A 500 ( 3.4A)None | 1.21A | 2c6nA-3oajA:undetectable | 2c6nA-3oajA:18.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p1v | METALLO-ENDOPEPTIDASE (Bacteroidesovatus) |
PF09471(Peptidase_M64)PF16217(M64_N) | 5 | HIS A 311GLU A 312HIS A 315TYR A 326TYR A 324 | ZN A 426 ( 3.3A)PO4 A 433 (-2.8A) ZN A 426 ( 3.3A)NonePO4 A 433 (-4.5A) | 0.55A | 2c6nA-3p1vA:undetectable | 2c6nA-3p1vA:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poy | NEUREXIN-1-ALPHA (Bos taurus) |
PF00008(EGF)PF02210(Laminin_G_2) | 5 | HIS A 555ALA A 553GLN A 557GLU A 761HIS A 862 | None | 1.28A | 2c6nA-3poyA:undetectable | 2c6nA-3poyA:20.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s5k | FALCILYSIN (Plasmodiumfalciparum) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C)PF08367(M16C_assoc) | 6 | ALA A 162HIS A 133GLU A 132HIS A 129GLU A 243TYR A1049 | None ZN A1194 (-4.0A) ZN A1194 ( 4.4A) ZN A1194 (-4.1A) ZN A1194 (-2.0A)None | 0.79A | 2c6nA-3s5kA:undetectable | 2c6nA-3s5kA:17.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sks | PUTATIVEOLIGOENDOPEPTIDASE F (Bacillusanthracis) |
no annotation | 5 | HIS A 356GLU A 357HIS A 360GLU A 384TYR A 487 | ZN A 568 ( 3.3A)PO4 A 566 (-3.2A) ZN A 568 ( 3.3A) ZN A 568 ( 2.0A)None | 0.80A | 2c6nA-3sksA:23.1 | 2c6nA-3sksA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sks | PUTATIVEOLIGOENDOPEPTIDASE F (Bacillusanthracis) |
no annotation | 5 | HIS A 356GLU A 357HIS A 360GLU A 384TYR A 490 | ZN A 568 ( 3.3A)PO4 A 566 (-3.2A) ZN A 568 ( 3.3A) ZN A 568 ( 2.0A)PO4 A 566 (-4.5A) | 0.38A | 2c6nA-3sksA:23.1 | 2c6nA-3sksA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u24 | PUTATIVE LIPOPROTEIN (Shewanellaoneidensis) |
PF05960(DUF885) | 5 | HIS A 427GLU A 428HIS A 433GLU A 458TYR A 543 | ZN A 595 (-3.1A) ZN A 595 ( 4.4A) ZN A 595 (-3.3A) ZN A 595 (-2.0A)None | 0.76A | 2c6nA-3u24A:4.0 | 2c6nA-3u24A:22.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u24 | PUTATIVE LIPOPROTEIN (Shewanellaoneidensis) |
PF05960(DUF885) | 5 | HIS A 427HIS A 433GLU A 458LYS A 529TYR A 543 | ZN A 595 (-3.1A) ZN A 595 (-3.3A) ZN A 595 (-2.0A)NoneNone | 0.92A | 2c6nA-3u24A:4.0 | 2c6nA-3u24A:22.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u9w | LEUKOTRIENE A-4HYDROLASE (Homo sapiens) |
PF01433(Peptidase_M1)PF09127(Leuk-A4-hydro_C) | 5 | HIS A1295GLU A1296HIS A1299GLU A1318TYR A1383 | ZN A2001 ( 3.2A)28P A7001 (-2.6A) ZN A2001 ( 3.2A) ZN A2001 ( 2.2A)28P A7001 (-4.6A) | 0.63A | 2c6nA-3u9wA:3.2 | 2c6nA-3u9wA:21.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vi1 | ALKALINEMETALLOPROTEINASE (Pseudomonasaeruginosa) |
PF08548(Peptidase_M10_C)PF13583(Reprolysin_4) | 5 | ALA A 135HIS A 176GLU A 177HIS A 180TYR A 216 | None ZN A 500 (-3.2A) ZN A 500 ( 4.2A) ZN A 500 (-3.3A)None | 0.44A | 2c6nA-3vi1A:3.1 | 2c6nA-3vi1A:24.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wqo | UNCHARACTERIZEDPROTEIN MJ1311 (Methanocaldococcusjannaschii) |
PF01261(AP_endonuc_2) | 5 | HIS A 78HIS A 231GLU A 260HIS A 222HIS A 119 | MN A1002 (-3.6A) MN A1001 (-3.6A) MN A1002 ( 4.9A) MN A1001 ( 4.9A) MN A1002 (-3.4A) | 1.08A | 2c6nA-3wqoA:undetectable | 2c6nA-3wqoA:17.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zuk | ENDOPEPTIDASE,PEPTIDASE FAMILY M13 (Mycobacteriumtuberculosis) |
PF01431(Peptidase_M13)PF05649(Peptidase_M13_N) | 5 | ALA A 453HIS A 493GLU A 494HIS A 497GLU A 560 | RDF A1665 (-4.3A) ZN A1664 ( 3.4A)RDF A1665 (-2.5A) ZN A1664 (-3.1A) ZN A1664 ( 2.3A) | 0.37A | 2c6nA-3zukA:4.4 | 2c6nA-3zukA:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zus | BOTULINUM NEUROTOXINTYPE A,SYNAPTOSOMAL-ASSOCIATED PROTEIN 23 (Clostridiumbotulinum;Homo sapiens) |
PF01742(Peptidase_M27)PF07952(Toxin_trans) | 5 | HIS A 223GLU A 224HIS A 227GLU A 262TYR A 366 | ZN A1916 (-3.3A) ZN A1916 ( 4.3A) ZN A1916 (-3.3A) ZN A1916 (-2.0A)None | 0.83A | 2c6nA-3zusA:2.2 | 2c6nA-3zusA:20.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ar9 | COLLAGENASE COLT (Clostridiumtetani) |
PF01752(Peptidase_M9) | 5 | HIS A 465GLU A 466HIS A 469GLU A 499TYR A 548 | ZN A1731 (-3.3A) ZN A1731 (-3.9A) ZN A1731 (-3.2A) ZN A1731 (-2.6A)None | 0.59A | 2c6nA-4ar9A:4.4 | 2c6nA-4ar9A:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b52 | BACILLOLYSIN (Paenibacilluspolymyxa) |
PF01447(Peptidase_M4)PF02868(Peptidase_M4_C) | 5 | ALA A 106HIS A 135GLU A 136HIS A 139GLU A 159 | RDF A 501 (-4.7A) ZN A 401 ( 3.2A)RDF A 501 (-2.5A) ZN A 401 ( 3.3A) ZN A 401 ( 1.9A) | 0.42A | 2c6nA-4b52A:5.4 | 2c6nA-4b52A:18.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4df9 | PUTATIVE PEPTIDASE (Bacteroidesfragilis) |
PF09471(Peptidase_M64)PF16217(M64_N) | 5 | HIS A 311GLU A 312HIS A 315TYR A 326TYR A 324 | ZN A 502 ( 3.2A)2PE A 504 (-4.1A) ZN A 502 (-3.3A)2PE A 504 (-4.1A)2PE A 504 (-3.8A) | 0.94A | 2c6nA-4df9A:2.8 | 2c6nA-4df9A:21.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fgm | AMINOPEPTIDASE NFAMILY PROTEIN (Idiomarinaloihiensis) |
PF05299(Peptidase_M61)PF13180(PDZ_2) | 5 | HIS A 273GLU A 274HIS A 277GLU A 307TYR A 377 | ZN A 602 ( 3.4A)MAE A 601 ( 3.5A) ZN A 602 ( 3.2A) ZN A 602 ( 2.3A)MAE A 601 (-4.7A) | 0.60A | 2c6nA-4fgmA:6.1 | 2c6nA-4fgmA:22.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fys | AMINOPEPTIDASE N (Homo sapiens) |
PF01433(Peptidase_M1)PF11838(ERAP1_C) | 6 | ALA A 353HIS A 388GLU A 389HIS A 392GLU A 411TYR A 477 | None | 0.74A | 2c6nA-4fysA:3.8 | 2c6nA-4fysA:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gaa | MGC78867 PROTEIN (Xenopus laevis) |
PF01433(Peptidase_M1)PF09127(Leuk-A4-hydro_C) | 5 | HIS A 292GLU A 293HIS A 296GLU A 315TYR A 380 | ZN A 701 ( 3.2A)BES A 702 (-2.6A) ZN A 701 ( 3.4A) ZN A 701 ( 1.7A)BES A 702 (-4.3A) | 0.62A | 2c6nA-4gaaA:3.3 | 2c6nA-4gaaA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iuw | NEUTRALENDOPEPTIDASE (Lactobacillusrhamnosus) |
PF01431(Peptidase_M13)PF05649(Peptidase_M13_N) | 5 | ALA A 437HIS A 477GLU A 478HIS A 481GLU A 537 | CIT A 702 (-4.2A) ZN A 701 ( 3.2A)CIT A 702 (-2.4A) ZN A 701 ( 3.4A) ZN A 701 ( 2.2A) | 0.31A | 2c6nA-4iuwA:3.8 | 2c6nA-4iuwA:22.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j1l | TETANUS TOXIN (Clostridiumtetani) |
PF01742(Peptidase_M27) | 5 | HIS A 233GLU A 234HIS A 237GLU A 271TYR A 375 | ZN A 501 (-3.5A) ZN A 501 ( 4.1A) ZN A 501 (-3.3A) ZN A 501 (-1.9A)None | 0.66A | 2c6nA-4j1lA:2.9 | 2c6nA-4j1lA:20.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j3b | M1 FAMILYAMINOPEPTIDASE (Plasmodiumfalciparum) |
PF01433(Peptidase_M1)PF11940(DUF3458)PF17432(DUF3458_C) | 6 | ALA A 461HIS A 496GLU A 497HIS A 500GLU A 519TYR A 580 | None ZN A1102 ( 3.2A)ARG A1101 (-2.5A) ZN A1102 ( 3.2A) ZN A1102 ( 2.1A)ARG A1101 (-4.5A) | 0.66A | 2c6nA-4j3bA:6.9 | 2c6nA-4j3bA:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k90 | EXTRACELLULARMETALLOPROTEINASEMEP (Aspergillusfumigatus) |
PF02128(Peptidase_M36) | 5 | ALA A 393HIS A 429GLU A 430HIS A 433GLU A 459 | MLA A 704 (-4.4A) ZN A 701 (-3.2A)MLA A 704 (-3.7A) ZN A 701 (-3.2A) ZN A 701 (-2.2A) | 0.33A | 2c6nA-4k90A:7.9 | 2c6nA-4k90A:22.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ka8 | OLIGOPEPTIDASE A (Arabidopsisthaliana) |
PF01432(Peptidase_M3) | 8 | ALA A 520HIS A 571GLU A 572HIS A 575GLU A 601HIS A 703TYR A 713TYR A 716 | None ZN A 801 (-3.3A) ZN A 801 ( 4.6A) ZN A 801 (-3.3A) ZN A 801 (-2.1A)NoneNoneNone | 0.33A | 2c6nA-4ka8A:20.6 | 2c6nA-4ka8A:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ka8 | OLIGOPEPTIDASE A (Arabidopsisthaliana) |
PF01432(Peptidase_M3) | 7 | GLN A 653ALA A 520HIS A 571GLU A 572HIS A 575HIS A 703TYR A 713 | NoneNone ZN A 801 (-3.3A) ZN A 801 ( 4.6A) ZN A 801 (-3.3A)NoneNone | 1.17A | 2c6nA-4ka8A:20.6 | 2c6nA-4ka8A:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kxb | GLUTAMYLAMINOPEPTIDASE (Homo sapiens) |
PF01433(Peptidase_M1)PF11838(ERAP1_C) | 6 | ALA A 358HIS A 393GLU A 394HIS A 397GLU A 416TYR A 479 | BES A1017 (-4.6A) ZN A1001 ( 3.3A)BES A1017 (-3.1A) ZN A1001 ( 3.2A) ZN A1001 ( 2.4A)BES A1017 (-4.2A) | 0.75A | 2c6nA-4kxbA:3.9 | 2c6nA-4kxbA:21.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nge | PRESEQUENCEPROTEASE,MITOCHONDRIAL (Homo sapiens) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C)PF08367(M16C_assoc) | 5 | ALA D 137HIS D 108HIS D 104GLU D 205TYR D 906 | None | 0.57A | 2c6nA-4ngeD:undetectable | 2c6nA-4ngeD:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p1c | TOLUENE-4-MONOOXYGENASE SYSTEM PROTEIN A (Pseudomonasmendocina) |
PF02332(Phenol_Hydrox) | 5 | ALA A 107HIS A 234GLU A 134HIS A 137GLU A 231 | PEG A 503 ( 4.1A) FE A 502 (-3.5A) FE A 501 (-2.5A) FE A 501 (-3.2A) FE A 502 (-2.3A) | 1.23A | 2c6nA-4p1cA:undetectable | 2c6nA-4p1cA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pj6 | LEUCYL-CYSTINYLAMINOPEPTIDASE (Homo sapiens) |
PF01433(Peptidase_M1)PF11838(ERAP1_C) | 5 | HIS A 464GLU A 465HIS A 468GLU A 487TYR A 549 | ZN A1101 ( 3.2A)LYS A1102 (-3.4A) ZN A1101 (-3.2A) ZN A1101 ( 1.9A)None | 0.81A | 2c6nA-4pj6A:5.5 | 2c6nA-4pj6A:23.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pkv | LETHAL FACTOR (Bacillusanthracis) |
PF07737(ATLF)PF09156(Anthrax-tox_M) | 5 | HIS A 686GLU A 687HIS A 690GLU A 735TYR A 728 | ZN A 802 ( 3.6A)30R A 801 (-2.8A) ZN A 802 ( 3.4A) ZN A 802 ( 2.5A)30R A 801 (-3.4A) | 0.59A | 2c6nA-4pkvA:3.3 | 2c6nA-4pkvA:22.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qko | PYOCIN-S2PYOCIN-S2 IMMUNITYPROTEIN (Pseudomonasaeruginosa) |
PF01320(Colicin_Pyocin)no annotation | 5 | GLN B 646ALA A 37GLN A 36HIS A 34TYR A 55 | None | 1.18A | 2c6nA-4qkoB:undetectable | 2c6nA-4qkoB:11.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qme | AMINOPEPTIDASE N (Neisseriameningitidis) |
PF01433(Peptidase_M1)PF11940(DUF3458)PF17432(DUF3458_C) | 6 | ALA A 258HIS A 293GLU A 294HIS A 297GLU A 316TYR A 377 | 37B A 901 (-3.8A)37B A 901 ( 3.2A)37B A 901 (-2.6A) ZN A 908 ( 3.2A) ZN A 908 ( 2.0A)GOL A 910 ( 2.6A) | 0.63A | 2c6nA-4qmeA:4.3 | 2c6nA-4qmeA:21.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wgk | NEUTRAL CERAMIDASE (Homo sapiens) |
PF04734(Ceramidase_alk)PF17048(Ceramidse_alk_C) | 5 | GLN A 471HIS A 303HIS A 194GLU A 540TYR A 579 | None ZN A 801 ( 3.2A) ZN A 801 ( 3.3A) ZN A 801 ( 2.0A) ZN A 801 ( 4.3A) | 1.11A | 2c6nA-4wgkA:undetectable | 2c6nA-4wgkA:22.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wz9 | AGAP004809-PA (Anophelesgambiae) |
PF01433(Peptidase_M1)PF11838(ERAP1_C) | 6 | ALA A 331HIS A 366GLU A 367HIS A 370GLU A 389TYR A 452 | None ZN A1001 (-3.3A) ZN A1001 ( 4.3A) ZN A1001 (-3.2A) ZN A1001 (-2.4A)None | 0.70A | 2c6nA-4wz9A:5.3 | 2c6nA-4wz9A:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xea | PEPTIDASE M16 DOMAINPROTEIN (Alicyclobacillusacidocaldarius) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C) | 5 | ALA A 94HIS A 71GLU A 70HIS A 67GLU A 142 | None NI A 502 (-3.4A) NI A 502 ( 4.6A) NI A 502 (-3.4A) NI A 502 (-3.1A) | 0.80A | 2c6nA-4xeaA:undetectable | 2c6nA-4xeaA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xmv | AMINOPEPTIDASE N (Escherichiacoli) |
PF01433(Peptidase_M1)PF11940(DUF3458)PF17432(DUF3458_C) | 6 | ALA A 262HIS A 297GLU A 298HIS A 301GLU A 320TYR A 381 | None ZN A 901 ( 3.2A)ARG A 902 (-2.8A) ZN A 901 ( 3.2A) ZN A 901 ( 2.1A)GOL A 910 ( 3.5A) | 0.67A | 2c6nA-4xmvA:3.1 | 2c6nA-4xmvA:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zkt | BONTOXILYSIN A (Clostridiumbotulinum) |
PF01742(Peptidase_M27)PF07951(Toxin_R_bind_C)PF07952(Toxin_trans)PF07953(Toxin_R_bind_N) | 5 | HIS A 212GLU A 213HIS A 216GLU A 251TYR A 351 | ZN A1301 (-3.7A) ZN A1301 (-3.3A) ZN A1301 (-3.7A) ZN A1301 (-2.3A) ZN A1301 (-4.8A) | 0.99A | 2c6nA-4zktA:2.3 | 2c6nA-4zktA:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zr5 | NEPRILYSIN (Oryctolaguscuniculus) |
PF01431(Peptidase_M13)PF05649(Peptidase_M13_N) | 5 | ALA A 544HIS A 584GLU A 585HIS A 588GLU A 647 | RDF A 802 (-4.1A) ZN A 801 ( 3.3A)RDF A 802 (-2.7A) ZN A 801 ( 3.2A) ZN A 801 ( 2.2A) | 0.36A | 2c6nA-4zr5A:4.3 | 2c6nA-4zr5A:22.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a2r | ANGIOTENSIN-CONVERTING ENZYME (Drosophilamelanogaster) |
PF01401(Peptidase_M2) | 12 | GLN A 265HIS A 337ALA A 338GLN A 361HIS A 367GLU A 368HIS A 371GLU A 395LYS A 495HIS A 497TYR A 504TYR A 507 | MLT A1615 (-3.2A)MLT A1615 (-3.8A)MLT A1615 ( 4.9A)None ZN A1616 (-3.2A)MLT A1615 (-4.3A) ZN A1616 (-3.3A) ZN A1616 (-2.4A)MLT A1615 (-2.7A)MLT A1615 (-4.0A)MLT A1615 (-4.7A)MLT A1615 (-4.0A) | 0.56A | 2c6nA-5a2rA:49.9 | 2c6nA-5a2rA:40.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a2r | ANGIOTENSIN-CONVERTING ENZYME (Drosophilamelanogaster) |
PF01401(Peptidase_M2) | 8 | HIS A 337ALA A 338HIS A 371GLU A 368GLU A 395HIS A 497TYR A 504TYR A 507 | MLT A1615 (-3.8A)MLT A1615 ( 4.9A) ZN A1616 (-3.3A)MLT A1615 (-4.3A) ZN A1616 (-2.4A)MLT A1615 (-4.0A)MLT A1615 (-4.7A)MLT A1615 (-4.0A) | 1.48A | 2c6nA-5a2rA:49.9 | 2c6nA-5a2rA:40.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a2r | ANGIOTENSIN-CONVERTING ENZYME (Drosophilamelanogaster) |
PF01401(Peptidase_M2) | 6 | HIS A 337GLN A 353HIS A 371HIS A 497TYR A 504TYR A 507 | MLT A1615 (-3.8A)None ZN A1616 (-3.3A)MLT A1615 (-4.0A)MLT A1615 (-4.7A)MLT A1615 (-4.0A) | 1.30A | 2c6nA-5a2rA:49.9 | 2c6nA-5a2rA:40.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a2r | ANGIOTENSIN-CONVERTING ENZYME (Drosophilamelanogaster) |
PF01401(Peptidase_M2) | 6 | HIS A 337GLN A 353LYS A 495HIS A 497TYR A 504TYR A 507 | MLT A1615 (-3.8A)NoneMLT A1615 (-2.7A)MLT A1615 (-4.0A)MLT A1615 (-4.7A)MLT A1615 (-4.0A) | 1.24A | 2c6nA-5a2rA:49.9 | 2c6nA-5a2rA:40.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a3y | THERMOLYSIN (Bacillusthermoproteolyticus) |
PF01447(Peptidase_M4)PF02868(Peptidase_M4_C) | 5 | ALA A 113HIS A 142GLU A 143HIS A 146GLU A 166 | VAL A1322 (-4.8A) ZN A1317 (-3.2A)VAL A1322 (-3.2A) ZN A1317 (-3.2A) ZN A1317 (-2.3A) | 0.51A | 2c6nA-5a3yA:6.0 | 2c6nA-5a3yA:21.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cio | PYRROLOQUINOLINEQUINONE BIOSYNTHESISPROTEIN PQQF (Serratia sp.FS14) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C) | 5 | ALA A 80HIS A 52GLU A 51HIS A 48GLU A 129 | None ZN A 801 (-3.2A)None ZN A 801 (-3.2A) ZN A 801 (-2.6A) | 0.80A | 2c6nA-5cioA:undetectable | 2c6nA-5cioA:22.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cuo | PHOSPHATEPROPANOYLTRANSFERASE (Rhodopseudomonaspalustris) |
PF06130(PTAC) | 5 | ALA A 154HIS A 48GLU A 109HIS A 50HIS A 159 | NoneCOA A 501 ( 3.0A) ZN A 503 (-2.3A) ZN A 503 ( 3.3A) ZN A 502 (-3.4A) | 1.25A | 2c6nA-5cuoA:undetectable | 2c6nA-5cuoA:15.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dll | AMINOPEPTIDASE N (Francisellatularensis) |
PF01433(Peptidase_M1)PF11940(DUF3458)PF17432(DUF3458_C) | 6 | ALA A 271HIS A 306GLU A 307HIS A 310GLU A 329TYR A 390 | None ZN A 901 (-3.3A) ZN A 901 ( 4.2A) ZN A 901 (-3.3A) ZN A 901 (-1.6A)None | 0.71A | 2c6nA-5dllA:5.4 | 2c6nA-5dllA:20.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e3x | THERMOSTABLECARBOXYPEPTIDASE 1 (Fervidobacteriumislandicum) |
PF02074(Peptidase_M32) | 5 | HIS A 253GLU A 254HIS A 257GLU A 283TYR A 407 | CO A 501 (-3.3A) CO A 501 ( 4.8A) CO A 501 (-3.3A) CO A 501 (-2.7A)None | 0.98A | 2c6nA-5e3xA:22.0 | 2c6nA-5e3xA:21.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5euf | PROTEASE (Helicobacterpylori) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C) | 5 | ALA A 109HIS A 82GLU A 81HIS A 78GLU A 158 | None ZN A 502 (-4.4A) ZN A 502 ( 4.2A) ZN A 502 (-3.3A) ZN A 502 (-2.6A) | 0.72A | 2c6nA-5eufA:undetectable | 2c6nA-5eufA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fxn | THERMOLYSIN (Bacillusthermoproteolyticus) |
PF01447(Peptidase_M4)PF02868(Peptidase_M4_C) | 5 | ALA A 113HIS A 142GLU A 143HIS A 146GLU A 166 | VAL A1318 (-4.6A) ZN A1317 (-3.2A)VAL A1318 (-3.1A) ZN A1317 (-3.3A) ZN A1317 (-2.2A) | 0.46A | 2c6nA-5fxnA:6.0 | 2c6nA-5fxnA:18.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ikn | DNA PRIMASE/HELICASE (Escherichiavirus T7) |
PF03796(DnaB_C)PF13155(Toprim_2) | 5 | HIS D 180ALA D 184GLU D 159HIS D 136TYR D 111 | None | 1.31A | 2c6nA-5iknD:undetectable | 2c6nA-5iknD:21.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j6s | ENDOPLASMICRETICULUMAMINOPEPTIDASE 2 (Homo sapiens) |
PF01433(Peptidase_M1)PF11838(ERAP1_C) | 6 | ALA A 335HIS A 370GLU A 371HIS A 374GLU A 393TYR A 455 | 6GA A1015 (-4.7A) ZN A1001 ( 3.2A)6GA A1015 (-3.0A) ZN A1001 ( 3.2A) ZN A1001 ( 1.7A)6GA A1015 (-4.0A) | 0.73A | 2c6nA-5j6sA:7.3 | 2c6nA-5j6sA:20.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kdx | METALLOPEPTIDASE (Pseudomonasaeruginosa) |
PF13402(Peptidase_M60) | 6 | GLN A 683HIS A 696GLU A 697HIS A 700GLU A 716TYR A 776 | None ZN A1005 ( 3.3A) ZN A1005 (-4.1A) ZN A1005 (-3.4A) ZN A1005 (-2.1A)TNR A1002 (-4.6A) | 1.45A | 2c6nA-5kdxA:2.8 | 2c6nA-5kdxA:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5l44 | K-26 DIPEPTIDYLCARBOXYPEPTIDASE (Astrosporangiumhypotensionis) |
PF01432(Peptidase_M3) | 5 | ALA A 418GLU A 464HIS A 467GLU A 492TYR A 599 | NoneK26 A1005 (-2.7A) ZN A1001 ( 3.4A) ZN A1001 ( 2.2A)None | 1.27A | 2c6nA-5l44A:19.6 | 2c6nA-5l44A:25.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5l44 | K-26 DIPEPTIDYLCARBOXYPEPTIDASE (Astrosporangiumhypotensionis) |
PF01432(Peptidase_M3) | 8 | ALA A 418HIS A 463GLU A 464HIS A 467GLU A 492HIS A 593TYR A 603TYR A 606 | None ZN A1001 ( 3.3A)K26 A1005 (-2.7A) ZN A1001 ( 3.4A) ZN A1001 ( 2.2A)K26 A1005 ( 3.3A)SO4 A1004 (-4.8A)SO4 A1004 ( 3.7A) | 0.40A | 2c6nA-5l44A:19.6 | 2c6nA-5l44A:25.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5o7e | COLH PROTEIN (Hathewayahistolytica) |
no annotation | 5 | HIS A 455GLU A 456HIS A 459GLU A 487TYR A 538 | ZN A 801 ( 3.3A)9NB A 803 (-3.5A)9NB A 803 ( 3.2A) ZN A 801 ( 2.3A)None | 0.56A | 2c6nA-5o7eA:4.5 | 2c6nA-5o7eA:8.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xey | PHLORETIN HYDROLASE (Mycobacteroidesabscessus) |
no annotation | 6 | HIS A 217GLN A 271HIS A 269GLU A 273HIS A 133GLU A 164 | None | 1.27A | 2c6nA-5xeyA:undetectable | 2c6nA-5xeyA:10.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6brs | PUTATIVE ZINCPROTEASE (Pectobacteriumatrosepticum) |
no annotation | 5 | ALA A 114HIS A 84GLU A 83HIS A 80GLU A 165 | NoneNone HG A1004 ( 4.5A) HG A1004 (-3.4A) HG A1004 (-2.8A) | 0.78A | 2c6nA-6brsA:undetectable | 2c6nA-6brsA:10.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bv2 | AMINOPEPTIDASE N (Sus scrofa) |
no annotation | 6 | ALA A 348HIS A 383GLU A 384HIS A 387GLU A 406TYR A 472 | SO4 A1027 (-4.3A) ZN A1035 (-3.2A)ILE A1024 ( 4.1A) ZN A1035 (-3.2A) ZN A1035 ( 2.2A)SO4 A1032 ( 4.1A) | 0.71A | 2c6nA-6bv2A:4.7 | 2c6nA-6bv2A:9.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bvd | LIGHT CHAIN (Clostridiumbotulinum) |
no annotation | 5 | HIS A 226GLU A 227HIS A 230GLU A 264TYR A 366 | ZN A 503 ( 3.3A)ACT A 502 (-2.6A) ZN A 503 (-3.3A) ZN A 503 ( 2.6A)None | 0.82A | 2c6nA-6bvdA:2.6 | 2c6nA-6bvdA:9.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6eom | MUTT/NUDIX FAMILYPROTEIN (Caldithrixabyssi) |
no annotation | 5 | ALA A 319HIS A 379GLU A 380HIS A 383GLU A 412 | None ZN A 601 (-3.2A)None ZN A 601 (-3.2A) ZN A 601 (-1.6A) | 0.78A | 2c6nA-6eomA:2.0 | 2c6nA-6eomA:8.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f4e | CATALYTIC DOMAIN OFBOTULINUM NEUROTOXINX (Clostridiumbotulinum) |
no annotation | 5 | HIS A 227GLU A 228HIS A 231GLU A 266TYR A 363 | None | 0.90A | 2c6nA-6f4eA:3.0 | 2c6nA-6f4eA:9.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fpc | PRO-PROENDOPEPTIDASE (Paenibacillusalvei) |
no annotation | 5 | HIS A 137GLU A 138HIS A 141GLU A 181TYR A 174 | ZN A 301 ( 3.4A) ZN A 301 ( 4.3A) ZN A 301 ( 3.4A) ZN A 301 ( 2.1A) ZN A 301 ( 4.8A) | 0.75A | 2c6nA-6fpcA:4.1 | 2c6nA-6fpcA:9.36 |